Search database
Filter
17
Text search: Covishield
Featured
Language
Document type
Guidelines
8
Fact sheets
4
Manuals
3
Situation Updates
1
Resource Platforms
1
Countries / Regions
Argentina
4
Brazil
2
Syria
1
Latin America and the Carribbean
1
Authors & Publishers
World Health Organization WHO
5
Ministerio de Salud Argentina
3
Africa CDC Centres for Disease Control and Prevention
2
African Union
2
Dirección de Control de Enfermedades Inmunoprevenibles
2
OPAS
2
Eastern Mediterranean Region
1
Feraud, H.
1
Ministerio de Salud, Argentina
1
OPAS, OMS
1
Organisation mondiale de la Santé OMS
1
Organización Mundial de la Salud OMS
1
Organização Mundial da Saúde (OMS)
1
Pan American Health Organisation PAHO
1
World Health Organization WHO, Regional Office of Europe
1
Publication Years
Category
Countries
8
Toolboxes
COVID-19
17
Conflict
1
 Download
  View PDF
 Add to my

Statement on Covishield and the European Union (EU) Digital COVID Certificate “Green Pass”

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC
 Download
  View PDF
 Add to my

Déclaration relative au vaccin Covishield ainsi que sur le passeport numérique de l’Union européenne (UE) sur le COVID intitulé “Pass vert”

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC
 Download
  View PDF
 Add to my

Recommandations provisoires concernant l’utilisation du vaccin ChAdOx1-S [‎recombinant]‎ contre la COVID-19 (‎vaccin anti-COVID-19 AZD1222 Vaxzevria™ d’AstraZeneca, COVISHIELD™ de SII)‎
recommended

World Health Organization WHO (2021) C_WHO
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
 Download
  View PDF
 Add to my

Предварительные рекомендации по применению вакцины ChAdOx1-S [‎рекомбинантной]‎ против COVID-19 (‎вакцина AstraZeneca COVID-19 AZD1222, Vaxzevria™, SII COVISHIELD™)
recommended

World Health Organization WHO (2021) C_WHO
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
 External Link
 Add to my

Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety on AstraZeneca COVID-19 vaccine

World Health Organization WHO (2021) C_WHO
7 April 2021 Based on current information, a causal relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed. Available in Englisch, French and Russian
 Download
  View PDF
 Add to my

Recomendações provisórias para o uso da vacina ChAdOx1-S [recombinante] contra COVID-19 (vacina AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™) - Última atualização em 30 de julho de 2021

OPAS, OMS OPAS (2021) CC
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
 External Link
 Add to my

ECC COVID-19 Situation Updates

Pan American Health Organisation PAHO (2022) C_WHO
This situation update is on the Novel Coronavirus (COVID-19) reported cases and deaths, Globally, Regionally, for Barbados and the Eastern Caribbean Countries, French Territories, and the United Kingdom Overseas Territories.
 External Link
 Add to my

WCO Syria Bi-Weekly Situation Report
recommended

World Health Organization WHO; Eastern Mediterranean Region (2021) C_WHO
 Download
  View PDF
 Add to my

Manual del Vacunador Vacuna SINOPHARM - 28 DE FEBRERO DE 2021

Dirección de Control de Enfermedades Inmunoprevenibles Ministerio de Salud Argentina (2021) CC
Vaccinator's Manual SINOPHARM Vaccine - 28 FEBRUARY 2021
 Download
  View PDF
 Add to my

Manual del Vacunador. Vacuna CONVIDECIA

Dirección de Control de Enfermedades Inmunoprevenibles Ministerio de Salud Argentina (2021) CC
Vaccinator's Manual. CONVIDECIA Vaccine
 Download
  View PDF
 Add to my

Job aid for COVID-19 vaccine administration: AZD1222 (‎ChAdOx1-S [‎recombinant]‎)‎ COVID-19 vaccine

World Health Organization WHO, Regional Office of Europe (2021) C_WHO
 Download
  View PDF
 Add to my

Éléments à prendre en considération lors de la mise en oeuvre et de l’ajustement des mesures de santé publique et des mesures sociales dans le cadre de l’épidémie de COVID-19
recommended

Organisation mondiale de la Santé OMS (2021) C_WHO
orientations provisoires, 14 juin 2021
 Download
  View PDF
 Add to my

Consideraciones para aplicar y ajustar medidas de salud pública y sociales en el contexto de la COVID-19
recommended

Organización Mundial de la Salud OMS (2021) C_WHO
orientaciones provisionales, 14 de junio de 2021
 Download
  View PDF
 Add to my

Considerações sobre a implementação e o ajuste de medidas de saúde pública e sociais no contexto da COVID-19 Orientação provisória 14 de junho de 2021

Organização Mundial da Saúde (OMS) OPAS (2021) CC
Considerations on the implementation and adjustment of public health and social measures in the context of COVID-19 Interim guidance 14 June 2021
 Download
  View PDF
 Add to my

Campaña Nacional de Vacunación contra la COVID-19 - Segundo Refuerzo - Argentina

Feraud, H. Ministerio de Salud Argentina (2022) C2
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de ... more
 Download
  View PDF
 Add to my

Guidance for clinical case management of thrombosis with thrombocytopenia syndrome‎ following vaccination to prevent coronavirus disease (‎COVID-19)‎ (Arabic)

World Health Organization WHO (2021) C_WHO
interim guidance, 19 July 2021 (arabic version)
 Download
  View PDF
 Add to my

Manual del Vacunador SEGUNDO REFUERZO Campaña Nacional de Vacunación contra la COVID-19

Ministerio de Salud, Argentina (2022) C1
Campaña Nacional de Vacunación contra la COVID-19